NewsBenzingaCIBC, 비스트라에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 181달러로 하향 조정 CIBC, 비스트라에 대한 ‘시장수익률 상회’ 의견 유지···목표주가 181달러로 하향 조정 Benzinga 2026.10.28 22:48 (GMT+0) Open on Benzinga Other news Fermium Research Maintains Buy on DuPont de Nemours, Raises Price Target to $160 Morgan Stanley Maintains Equal-Weight on Allegion, Raises Price Target to $181 Morgan Stanley Maintains Overweight on Advanced Energy Indus, Lowers Price Target to $368 Oppenheimer Maintains Outperform on BioMarin Pharmaceutical, Lowers Price Target to $94 Truist Securities Reiterates Hold on V2X, Raises Price Target to $87 Anthropic is still grappling with the economics of compute
